210 related articles for article (PubMed ID: 29855618)
1. Targeted Delivery of Cell Penetrating Peptide Virus-like Nanoparticles to Skin Cancer Cells.
Gan BK; Yong CY; Ho KL; Omar AR; Alitheen NB; Tan WS
Sci Rep; 2018 May; 8(1):8499. PubMed ID: 29855618
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of 5-fluorouracil-1-acetic acid (5-FA) to cancer cells overexpressing epithelial growth factor receptor (EGFR) using virus-like nanoparticles.
Gan BK; Rullah K; Yong CY; Ho KL; Omar AR; Alitheen NB; Tan WS
Sci Rep; 2020 Oct; 10(1):16867. PubMed ID: 33033330
[TBL] [Abstract][Full Text] [Related]
3. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
[TBL] [Abstract][Full Text] [Related]
4. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
[TBL] [Abstract][Full Text] [Related]
5. Peptide ligand-mediated endocytosis of nanoparticles to cancer cells: Cell receptor-binding- versus cell membrane-penetrating peptides.
Jo E; Heo JS; Lim JY; Lee BR; Yoon CJ; Kim J; Lee J
Biotechnol Bioeng; 2018 Jun; 115(6):1437-1449. PubMed ID: 29460954
[TBL] [Abstract][Full Text] [Related]
6. The Primary Mechanism of Cellular Internalization for a Short Cell- Penetrating Peptide as a Nano-Scale Delivery System.
Liu BR; Huang YW; Korivi M; Lo S-Y; Aronstam RS; Lee H-J
Curr Pharm Biotechnol; 2017; 18(7):569-584. PubMed ID: 28828981
[TBL] [Abstract][Full Text] [Related]
7. Modularized peptides modified HBc virus-like particles for encapsulation and tumor-targeted delivery of doxorubicin.
Shan W; Zhang D; Wu Y; Lv X; Hu B; Zhou X; Ye S; Bi S; Ren L; Zhang X
Nanomedicine; 2018 Apr; 14(3):725-734. PubMed ID: 29275067
[TBL] [Abstract][Full Text] [Related]
8. Acid-sensitive hybrid polymeric micelles containing a reversibly activatable cell-penetrating peptide for tumor-specific cytoplasm targeting.
Tang B; Zaro JL; Shen Y; Chen Q; Yu Y; Sun P; Wang Y; Shen WC; Tu J; Sun C
J Control Release; 2018 Jun; 279():147-156. PubMed ID: 29653223
[TBL] [Abstract][Full Text] [Related]
9. UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma.
Zhang B; Zhang Y; Liao Z; Jiang T; Zhao J; Tuo Y; She X; Shen S; Chen J; Zhang Q; Jiang X; Hu Y; Pang Z
Biomaterials; 2015 Jan; 36():98-109. PubMed ID: 25443789
[TBL] [Abstract][Full Text] [Related]
10. X-pep, a novel cell-penetrating peptide motif derived from the hepatitis B virus.
Montrose K; Yang Y; Krissansen GW
Biochem Biophys Res Commun; 2014 Oct; 453(1):64-8. PubMed ID: 25251474
[TBL] [Abstract][Full Text] [Related]
11. A retro-inverso cell-penetrating peptide for siRNA delivery.
Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
[TBL] [Abstract][Full Text] [Related]
12. Structure optimisation to improve the delivery efficiency and cell selectivity of a tumour-targeting cell-penetrating peptide.
Cao XW; Yang XZ; Du X; Fu LY; Zhang TZ; Shan HW; Zhao J; Wang FJ
J Drug Target; 2018 Nov; 26(9):777-792. PubMed ID: 29303375
[TBL] [Abstract][Full Text] [Related]
13. Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery.
Lee KW; Tey BT; Ho KL; Tejo BA; Tan WS
Mol Pharm; 2012 Sep; 9(9):2415-23. PubMed ID: 22775561
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Delivery of Nanoparticles with Cell Penetrating Peptides.
Salzano G; Torchilin VP
Methods Mol Biol; 2015; 1324():357-68. PubMed ID: 26202282
[TBL] [Abstract][Full Text] [Related]
15. Effective capture of proteins inside living cells by antibodies indirectly linked to a novel cell-penetrating polymer-modified protein A derivative.
Itakura S; Hama S; Ikeda H; Mitsuhashi N; Majima E; Kogure K
FEBS J; 2015 Jan; 282(1):142-52. PubMed ID: 25315678
[TBL] [Abstract][Full Text] [Related]
16. pH-responsive Virus-like Nanoparticles with Enhanced Tumour-targeting Ligands for Cancer Drug Delivery.
Biabanikhankahdani R; Alitheen NBM; Ho KL; Tan WS
Sci Rep; 2016 Nov; 6():37891. PubMed ID: 27883070
[TBL] [Abstract][Full Text] [Related]
17. siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.
Al Soraj M; He L; Peynshaert K; Cousaert J; Vercauteren D; Braeckmans K; De Smedt SC; Jones AT
J Control Release; 2012 Jul; 161(1):132-41. PubMed ID: 22465675
[TBL] [Abstract][Full Text] [Related]
18. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
Walrant A; Cardon S; Burlina F; Sagan S
Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
[TBL] [Abstract][Full Text] [Related]
19. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
20. Kinetic uptake profiles of cell penetrating peptides in lymphocytes and monocytes.
Rodrigues M; de la Torre BG; Andreu D; Santos NC
Biochim Biophys Acta; 2013 Oct; 1830(10):4554-63. PubMed ID: 23707662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
